Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal acetate tablets for emergency contraception within 72–120 hours
CTR20150044Phase 3Active
- Sponsor
- Zhejiang Xianju Pharmaceutical Co., Ltd.
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ulipristal, sponsored by Zhejiang Xianju Pharmaceutical Co., Ltd.. Started Feb 2015; status: active.
02
Drugs
ulipristal
Beyond the preview
Go deeper on CTR20150044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150044.